SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRN |
Texto Completo: | https://repositorio.ufrn.br/handle/123456789/55488 https://doi.org/10.3390/nu14153154 |
Resumo: | It is already established that sarcopenia is associated with adverse outcomes; however, few studies have focused on patients who have suffered an acute cardiovascular event. The use of SARC-F, a 5-item sarcopenia screening questionnaire, in these patients remains to be investigated. We aimed to investigate whether SARC-F can predict adverse outcomes in patients admitted to a hospital with a suspected infarction. This is a 1-year prospective cohort study. During hospitalization, patients completed the SARC-F questionnaire (scores ≥ 4 considered positive for the risk of sarcopenia). Length of hospital stay (LOS), new hospital admission, myocardial infarction, and cardiovascular mortality were collected via medical records and phone interviews. In total, 180 patients were evaluated. The median age was 60.6 years; 72.3% of the participants were men, and half of the sample had comorbidities. The median SARC-F score was 1.0 (interquartile range, 0–3.0), and 21.1% of the participants screened positive. Risk of sarcopenia was independently associated with longer LOS (odds ratio, 2.34; 95% CI, 1.09–5.04; p = 0.030) and hospital readmission (odds ratio, 3.73; 95% CI, 1.60–8.69; p = 0.002). One-fifth of post-acute cardiovascular event patients in this cohort screened positive for sarcopenia using the SARC-F screening questionnaire. Positive scores were associated with a longer LOS and hospital readmission |
id |
UFRN_27700759c31a2513094df724860fd9a9 |
---|---|
oai_identifier_str |
oai:https://repositorio.ufrn.br:123456789/55488 |
network_acronym_str |
UFRN |
network_name_str |
Repositório Institucional da UFRN |
repository_id_str |
|
spelling |
Fayh, Ana Paula TrussardiGuedes, Francisco Felipe de OliveiraCalado, Guilherme Carlos FilgueiraQueiroz, Sandra AzevedoAnselmo, Marina Gabriely Gomes BarbosaSousa, Iasmin Matias de2023-11-29T19:19:29Z2023-11-29T19:19:29Z2022-07FAYH, Ana Paula Trussardi; GUEDES, Francisco Felipe de Oliveira; CALADO, Guilherme Carlos Filgueira; QUEIROZ, Sandra Azevedo; ANSELMO, Marina Gabriely Gomes Barbosa; SOUSA, Iasmin Matias de. SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event. Nutrients, [S.l.], v. 14, p. 3154, 30 jul. 2022. DOI: https://doi.org/10.3390/nu14153154. Disponível em: https://www.mdpi.com/2072-6643/14/15/3154. Acesso em: 14 nov.2023.https://repositorio.ufrn.br/handle/123456789/55488https://doi.org/10.3390/nu14153154NutrientsAttribution 3.0 Brazilhttp://creativecommons.org/licenses/by/3.0/br/info:eu-repo/semantics/openAccessSarcopeniacardiovascular diseaseacute myocardium infarctionSARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular eventinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleIt is already established that sarcopenia is associated with adverse outcomes; however, few studies have focused on patients who have suffered an acute cardiovascular event. The use of SARC-F, a 5-item sarcopenia screening questionnaire, in these patients remains to be investigated. We aimed to investigate whether SARC-F can predict adverse outcomes in patients admitted to a hospital with a suspected infarction. This is a 1-year prospective cohort study. During hospitalization, patients completed the SARC-F questionnaire (scores ≥ 4 considered positive for the risk of sarcopenia). Length of hospital stay (LOS), new hospital admission, myocardial infarction, and cardiovascular mortality were collected via medical records and phone interviews. In total, 180 patients were evaluated. The median age was 60.6 years; 72.3% of the participants were men, and half of the sample had comorbidities. The median SARC-F score was 1.0 (interquartile range, 0–3.0), and 21.1% of the participants screened positive. Risk of sarcopenia was independently associated with longer LOS (odds ratio, 2.34; 95% CI, 1.09–5.04; p = 0.030) and hospital readmission (odds ratio, 3.73; 95% CI, 1.60–8.69; p = 0.002). One-fifth of post-acute cardiovascular event patients in this cohort screened positive for sarcopenia using the SARC-F screening questionnaire. Positive scores were associated with a longer LOS and hospital readmissionengreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNORIGINALSARC-FPredictorLongerLOS_Fayh_2022.pdfSARC-FPredictorLongerLOS_Fayh_2022.pdfapplication/pdf768814https://repositorio.ufrn.br/bitstream/123456789/55488/1/SARC-FPredictorLongerLOS_Fayh_2022.pdf6c85e3cd03f65b38024bc7752a472eb9MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8914https://repositorio.ufrn.br/bitstream/123456789/55488/2/license_rdf4d2950bda3d176f570a9f8b328dfbbefMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81484https://repositorio.ufrn.br/bitstream/123456789/55488/3/license.txte9597aa2854d128fd968be5edc8a28d9MD53123456789/554882023-11-29 16:20:35.057oai:https://repositorio.ufrn.br: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Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2023-11-29T19:20:35Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false |
dc.title.pt_BR.fl_str_mv |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event |
title |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event |
spellingShingle |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event Fayh, Ana Paula Trussardi Sarcopenia cardiovascular disease acute myocardium infarction |
title_short |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event |
title_full |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event |
title_fullStr |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event |
title_full_unstemmed |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event |
title_sort |
SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event |
author |
Fayh, Ana Paula Trussardi |
author_facet |
Fayh, Ana Paula Trussardi Guedes, Francisco Felipe de Oliveira Calado, Guilherme Carlos Filgueira Queiroz, Sandra Azevedo Anselmo, Marina Gabriely Gomes Barbosa Sousa, Iasmin Matias de |
author_role |
author |
author2 |
Guedes, Francisco Felipe de Oliveira Calado, Guilherme Carlos Filgueira Queiroz, Sandra Azevedo Anselmo, Marina Gabriely Gomes Barbosa Sousa, Iasmin Matias de |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Fayh, Ana Paula Trussardi Guedes, Francisco Felipe de Oliveira Calado, Guilherme Carlos Filgueira Queiroz, Sandra Azevedo Anselmo, Marina Gabriely Gomes Barbosa Sousa, Iasmin Matias de |
dc.subject.por.fl_str_mv |
Sarcopenia cardiovascular disease acute myocardium infarction |
topic |
Sarcopenia cardiovascular disease acute myocardium infarction |
description |
It is already established that sarcopenia is associated with adverse outcomes; however, few studies have focused on patients who have suffered an acute cardiovascular event. The use of SARC-F, a 5-item sarcopenia screening questionnaire, in these patients remains to be investigated. We aimed to investigate whether SARC-F can predict adverse outcomes in patients admitted to a hospital with a suspected infarction. This is a 1-year prospective cohort study. During hospitalization, patients completed the SARC-F questionnaire (scores ≥ 4 considered positive for the risk of sarcopenia). Length of hospital stay (LOS), new hospital admission, myocardial infarction, and cardiovascular mortality were collected via medical records and phone interviews. In total, 180 patients were evaluated. The median age was 60.6 years; 72.3% of the participants were men, and half of the sample had comorbidities. The median SARC-F score was 1.0 (interquartile range, 0–3.0), and 21.1% of the participants screened positive. Risk of sarcopenia was independently associated with longer LOS (odds ratio, 2.34; 95% CI, 1.09–5.04; p = 0.030) and hospital readmission (odds ratio, 3.73; 95% CI, 1.60–8.69; p = 0.002). One-fifth of post-acute cardiovascular event patients in this cohort screened positive for sarcopenia using the SARC-F screening questionnaire. Positive scores were associated with a longer LOS and hospital readmission |
publishDate |
2022 |
dc.date.issued.fl_str_mv |
2022-07 |
dc.date.accessioned.fl_str_mv |
2023-11-29T19:19:29Z |
dc.date.available.fl_str_mv |
2023-11-29T19:19:29Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
FAYH, Ana Paula Trussardi; GUEDES, Francisco Felipe de Oliveira; CALADO, Guilherme Carlos Filgueira; QUEIROZ, Sandra Azevedo; ANSELMO, Marina Gabriely Gomes Barbosa; SOUSA, Iasmin Matias de. SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event. Nutrients, [S.l.], v. 14, p. 3154, 30 jul. 2022. DOI: https://doi.org/10.3390/nu14153154. Disponível em: https://www.mdpi.com/2072-6643/14/15/3154. Acesso em: 14 nov.2023. |
dc.identifier.uri.fl_str_mv |
https://repositorio.ufrn.br/handle/123456789/55488 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.3390/nu14153154 |
identifier_str_mv |
FAYH, Ana Paula Trussardi; GUEDES, Francisco Felipe de Oliveira; CALADO, Guilherme Carlos Filgueira; QUEIROZ, Sandra Azevedo; ANSELMO, Marina Gabriely Gomes Barbosa; SOUSA, Iasmin Matias de. SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event. Nutrients, [S.l.], v. 14, p. 3154, 30 jul. 2022. DOI: https://doi.org/10.3390/nu14153154. Disponível em: https://www.mdpi.com/2072-6643/14/15/3154. Acesso em: 14 nov.2023. |
url |
https://repositorio.ufrn.br/handle/123456789/55488 https://doi.org/10.3390/nu14153154 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
Attribution 3.0 Brazil http://creativecommons.org/licenses/by/3.0/br/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution 3.0 Brazil http://creativecommons.org/licenses/by/3.0/br/ |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Nutrients |
publisher.none.fl_str_mv |
Nutrients |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRN instname:Universidade Federal do Rio Grande do Norte (UFRN) instacron:UFRN |
instname_str |
Universidade Federal do Rio Grande do Norte (UFRN) |
instacron_str |
UFRN |
institution |
UFRN |
reponame_str |
Repositório Institucional da UFRN |
collection |
Repositório Institucional da UFRN |
bitstream.url.fl_str_mv |
https://repositorio.ufrn.br/bitstream/123456789/55488/1/SARC-FPredictorLongerLOS_Fayh_2022.pdf https://repositorio.ufrn.br/bitstream/123456789/55488/2/license_rdf https://repositorio.ufrn.br/bitstream/123456789/55488/3/license.txt |
bitstream.checksum.fl_str_mv |
6c85e3cd03f65b38024bc7752a472eb9 4d2950bda3d176f570a9f8b328dfbbef e9597aa2854d128fd968be5edc8a28d9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN) |
repository.mail.fl_str_mv |
|
_version_ |
1814832683765727232 |